Q4 2025 earnings

Turning Point Brands shares fell 16.5% despite Q4 earnings beat and Modern Oral's 266% surge, as declining Zig-Zag sales disappointed investors.

LeMaitre Vascular will present at five major healthcare investment conferences in March 2026, engaging with institutional investors and analysts about corporate strategy and growth opportunities.

Delek Logistics hit record $536M EBITDA in 2025, boosted acquisitions and infrastructure expansion. Company raised distributions for 52nd consecutive quarter while diversifying revenue away from sponsor.

D-Wave stock surged 10% on strong Q4 results showing 179% revenue growth and robust bookings. The company acquired Quantum Circuits to expand capabilities amid growing quantum computing demand.

iQIYI reports 7% revenue decline and swung to net loss in 2025 due to weak ad spending and reduced content releases, though international operations show promise.

Sinclair projects strong 2026 growth driven by political ad spending and sports programming, expecting $333M in political ads and $700-740M Adjusted EBITDA.

Arcutis reported 2025 revenue of $372.1M (123% growth) and raised 2026 guidance to $480-495M, driven by strong ZORYVE adoption and positive clinical data.

Quaker Chemical expects mid-single digit growth through 2027, driven by organic share gains and the Dipsol acquisition, while targeting 36-37% gross margins despite flat Q4 volumes.

Barclays slashed NuScale Power's price target 67% to $15, joining Goldman Sachs in downgrading the small modular reactor developer amid concerns about commercialization viability.

Forum Energy Technologies beat Q4 earnings estimates and raised 2026 outlook, projecting 6% revenue growth and 16% EBITDA increase. Stock jumped 6.84%.

Walmart, Wayfair, and EPAM report strong Q4 earnings, driven by eCommerce growth and enterprise tech spending. All three issued positive 2026 guidance.

Opendoor surges 18% on better-than-expected Q4 earnings, showing improving margins and operational efficiency as path to profitability strengthens.

Trilogy Metals shares tumbled after reporting a $42.2 million full-year loss and major investor Paulson & Co. exiting its position entirely.

McDonald's beat Q4 earnings expectations with $7.01B revenue, but takes a cautious 2026 outlook amid wage inflation and commodity cost pressures.

Myriad Genetics reports 2025 results February 23, 2026, while preparing March launch of Precise MRD cancer detection product. Strong clinical data supports expansion.

Elkem's Q4 earnings fell 24% amid weak markets, but cost controls helped. Company divests Silicones division to Bluestar, skipping dividends due to equity impact.